Pain Management via a Subcutaneous Infusion of Ketamine in a Patient with Complex Regional Pain Syndrome - A case report -
![]() |
Suh, Jeong Hun
(Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine)
Koo, Mi Suk (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) Nahm, Francis Sahngun (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) Shin, Hwa Yong (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) Choi, Yong Min (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) Jo, Ji Yon (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) Lee, Sang Chul (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) Kim, Yong Chul (Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine) |
1 | Orser SA, Pcnncfathcr PS, MacDonald JF: Multiple mechanisms of kctaminc blockade of Ncmcthyl-Dcaspartatc receptors. Anesthesiology 1997; 86: 903 -17 DOI ScienceOn |
2 | Smith DJ, Boucbal RL. deSancris CA, Monroe PJ, Amedro JB. Perrotti JM. et al: Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology 1987; 26: 1253-60 DOI ScienceOn |
3 | Cbaplan SR. Malmberg AB. Yaksh TL: Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia ami nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther 1997; 280: 829-38 |
4 | Hocking G, Cous ins MJ: Ketamine in chronic pain management : an evidence-based review. Anesth Analg 2003: 97: 1730-9 DOI ScienceOn |
5 | Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE: Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med 2004; 5: 263-75 DOI ScienceOn |
6 | Mercadante S, Lodi F, Sapio M, Calligara M, Serretta R: Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J Pain Symptom Manage 1995; 10: 564-8 DOI ScienceOn |
7 | Kryslal JH, Karpcr LP, Scihyl JP, Freeman GK, Delancy R, Bremner JD, et al: Subanesthetie effect of the noncompetitivc NMDA antagonist, ketamine, in humans : Psychotomimetic, pcrcepilial, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994: 51: 199-21 DOI ScienceOn |
8 | Srubhaug A, Breivik H, Eide PK, Kreuncn M, Foss A: Mapping of punctuate hyperal gesia around a surgical incision demonstrates thai kctaminc is a powerful suppressor of central sensitization 10 pain following surgery. Acta Anacsthesiol Scand 1997; 41: 1124-32 DOI ScienceOn |
9 | Haley JE, Sullivan AF, Dickenson AH: Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociccptio n in the rat. Brain Res 1990; 518: 218-26 DOI ScienceOn |
10 | Eide PK, Stubhaug A, Brcivik H, Oye I: Reply to S.T. Meller: Ketamine: relief from chronic pain through actions at the NMOA receptor. Pain 1997; 72: 289-91 DOI ScienceOn |
11 | Woolf CJ: American College of Physic ians. American Physiological Society: Pain : moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004; 140: 441-51 DOI ScienceOn |
12 | South SM, Kohno T, Kaspar BK, Hegarty D, Vissd B, Drake CT, et al: A conditional deletion of the NRI subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. J Neurosci 2003; 23: 5031-40 DOI |
13 | Mannion RJ. Woolf CJ: Pain mechanisms and management: a central perspective. Clin J Pain 2000; 16(Suppl 3): 144-56 DOI ScienceOn |
14 | Eidc K. Stubhaug A. Oye I. Brcivik H: Cominuolls subcutaneous adminislrat ion of Ihc N-methyl-D-aspank acid (NMDA) receplor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 1995 : 61: 221-8 DOI ScienceOn |
15 | Koffler SP, Hampstead BM, Irani F, Tinker J, Kiefer RT, Rohr P, et al: The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol 2007; 22: 719-29 DOI ScienceOn |
16 | Goldberg ME, Domsky R, Scaringe D, Hirsh R, Dotson J, Sharaf I, et al: Multi-clay low dose ketamine infusion for the treatment of complex regional pain syndrome. Pain Physician 2005; 8: 175-9 |
17 | Kiefer RT, Rohr P, Ploppa A, Altemcyer KH, Schwarzman RJ: Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam. Pain Pract 2007; 7: 147-50 DOI ScienceOn |
18 | Fisher K, Ccxlcrrc TJ, Hagen NA: Targeling Ihe N-melhyl-D- aspartate receptor for chronic pain management: Preclinical animal siudies, recent clinical experience and future research directions. J Pain Symptom Manage 2000: 20: 358-73 DOI ScienceOn |
19 | Villanueva-Perez VL. Cerda-Olmedo G. Samper JM. Minguez A. Monsalve V, Bayona MJ. et al: Oral keraminc for the treatment of type I complex regional pain syndrome. Pain Pract 2007; 7: 39-43 DOI ScienceOn |
20 | Webster LR, Walker MJ: Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain. Am J Ther 2006; 13: 300-5 DOI ScienceOn |
21 | Woolf CJ. Mannion RJ: Neuropathic pain: aetiology. symptoms, mechanisms, and management. Lancet 1999; 353: 1959-64 DOI ScienceOn |
![]() |